top of page
stock-photo-cells-under-a-microscope-stem-cell-research-cell-therapy-cell-division-d-illus

About Me

Alexandra Günzl, PhD
Independent Non-Clinical Consultant

As non-clinical expert I provide independent, flexible, and practical hands-on support to my clients across the full range of non-clinical activities, tackling different questions and challenges.


With a strong scientific background in cancer research and a postgraduate education in regulatory affairs, I have worked as a non-clinical consultant for more than 15 years.

​

I have extensive experience supporting non-clinical development and regulatory strategies for a broad range of therapeutic modalities:

  • Small molecules

  • Biotechnology-derived products (including monoclonal antibodies, recombinant proteins, peptides, antibody-like molecules)

  • Advanced therapy medicinal products (ATMPs) / cellular and gene therapies (CGTs), with a particular focus on cell-based therapies

  • Radiopharmaceuticals

  • Substance-based medical devices.

Alexandra Günzl, PhD, independent non-clinical consultant with expertise in drug development, toxicology, regulatory affairs and scientific writing.

Work Experience

  • Since 2023 Independent Non-Clinical Consultant, Founder and Owner of Karyon Biopharma Consulting e.U.

  • 2015-2022 Consultant | MC Toxicology Consulting GmbH​

  • 2012-2015 Junior Consultant | MC Toxicology Consulting GmbH

  • 2009-2013 PhD Student | Medical University Vienna

  • 2008-2012 Trainee (in parallel to PhD studies) | MC Toxicology Consulting GmbH

Education and Training

  • ​2015-2016 Regulatory Affairs Manager | Postgraduate Program “Regulatory Affairs for Biopharmaceuticals including ATMPs” | European Centre for Regulatory Affairs (EUCRAF) 

  • 2009-2013 PhD Studies “Malignant Diseases” | Medical University Vienna

  • 2004-2008 Master of Science in Natural Sciences (DI(FH)) | Biotechnology – Biomedicine | University of Applied Sciences Campus Wien

bottom of page